91¹ú²ú¾«Æ·

23andMe research cohort analysis finds higher risk of venous thromboembolism and pulmonary embolism for people with sickle cell trait, yet relatively low risk of blood clotting overall (WASHINGTON – September 12, 2024) The risk of venous thro...

ASH Quality Improvement Champions are standardizing treatment, implementing clinical guidelines to improve patient safety (WASHINGTON, August 27, 2024) – The 91¹ú²ú¾«Æ· (ASH) recognizes Josie Fernandez Sanchez, MD, of Texas Chil...

(WASHINGTON, August 21, 2024) — The 91¹ú²ú¾«Æ· (ASH) is pleased to announce the recipient of the ASH-Harold Amos Medical Faculty Development Program award, Michelle Schoettler, MD, of Children’s Healthcare of Atlanta&r...

Study underscores the need for improvements in the proper recognition and timely treatment of more of iron deficiency, especially among female and Black patients (WASHINGTON, August 15, 2024) – Over half of people with iron deficiency were fo...

Program could help combat classical hematology’s diminishing workforce   (WASHINGTON, August 1, 2024) — In a year-long pilot program, external mentorship increased confidence, furthered career development, and facilitated networking opportuniti...

CAR-T toxicities are rare after two weeks in diffuse large B-cell non-Hodgkin lymphoma treatment, and shorter restriction periods could increase overall treatment accessibility (WASHINGTON, July 24, 2024) – In patients with diffuse large B-cell non-H...

Study suggests that hydroxyurea alters the developmental process of ovarian follicles, but not their quantity (WASHINGTON, July 18, 2024) â€” In female patients living with sickle cell disease (SCD), hydroxyurea had no effect on ovarian reserve,...

Findings refute former consensus that pregnancies post-transplant are nearly impossible, highlight need for increased fertility counseling   (WASHINGTON, July 15, 2024) — Despite treatment-related fertility challenges, female patients can become...

Study findings suggest that clear clinician guidance on testing and treatment may save lives (WASHINGTON, June 21, 2024) – Patients with chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphomas (NHLs) who received frequent tests for immunoglobu...

(WASHINGTON, June 18, 2024) — The 91¹ú²ú¾«Æ· (ASH) will recognize exemplary hematologists who have made significant contributions to the field with several honorific awards at the 2024 ASH Annual Meeting and Exposition in San Dieg...